Mitochondrial mutagenesis correlates with the local inflammatory environment in arthritis

Annals of the Rheumatic Diseases

Volumn 71, Issue 4, 2012, Pages 582-588

  Harty, Leonard C ^a   Biniecka, Monika ^a   O'Sullivan, Jacintha ^b   Fox, Edward ^c   Mulhall, Kevin ^d   Veale, Douglas J ^a   Fearon, Ursula ^a  

^a ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

^b ST JAMES S HOSPITAL   (Ireland)

^c UNIVERSITY OF WASHINGTON   (United States)

^d MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 1BETA; INTERLEUKIN 6; MITOCHONDRIAL DNA; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTHROSCOPY; ARTICLE; CD3+ T LYMPHOCYTE; CELL ASSAY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOHISTOLOGY; IN VITRO STUDY; IN VIVO STUDY; JOINT BIOPSY; MACROPHAGE; MALE; MICROSCOPY; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRIAL RANDOM MUTATION CAPTURE ASSAY; MITOCHONDRION; MUTAGENESIS; MUTATION RATE; OXIDATIVE STRESS; POINT MUTATION; PRIORITY JOURNAL; PROTEIN SYNTHESIS REGULATION; PSORIATIC ARTHRITIS; RHEUMATOID ARTHRITIS; RHEUMATOID ARTHRITIS SYNOVIAL FIBROBLAST CELL; SYNOVIAL FLUID; TISSUE CULTURE; VISUAL ANALOG SCALE;

ADULT; ANTIRHEUMATIC AGENTS; ARTHRITIS, PSORIATIC; ARTHRITIS, RHEUMATOID; ARTHROSCOPY; BIOLOGICAL AGENTS; BIOPSY; CELLS, CULTURED; DNA, MITOCHONDRIAL; FEMALE; HUMANS; INFLAMMATION MEDIATORS; MALE; MIDDLE AGED; MITOCHONDRIA; MUTAGENESIS; MUTATION; SYNOVIAL MEMBRANE; SYNOVITIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84857918542     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2011-200245     Document Type: Article

References (42)

1. Ng CT, Biniecka M, Kennedy A, et al. Synovial tissue hypoxia and inflammation in vivo. Ann Rheum Dis 2010;69:1389-95.
2. Kennedy A, Ng CT, Biniecka M, et al. Angiogenesis and blood vessel stability in inflammatory arthritis. Arthritis Rheum 2010;62:711-21.
3. Hamanaka RB, Chandel NS. Mitochondrial reactive oxygen species regulate hypoxic signaling. Curr Opin Cell Biol 2009;21:894-9.
4. Biniecka M, Kennedy A, Fearon U, et al. Oxidative damage in synovial tissue is associated with in vivo hypoxic status in the arthritic joint. Ann Rheum Dis 2010;69:1172-8.
5. Kumagai T, Matsukawa N, Kaneko Y, et al. A lipid peroxidation-derived inflammatory mediator: identification of 4-hydroxy-2-nonenal as a potential inducer of cyclooxygenase-2 in macrophages. J Biol Chem 2004;279:48389-96. (Pubitemid 39540995)
6. Page S, Fischer C, Baumgartner B, et al. 4-Hydroxynonenal prevents NF-kappaB activation and tumor necrosis factor expression by inhibiting IkappaB phosphorylation and subsequent proteolysis. J Biol Chem 1999;274:11611-8.
7. Distler JH, Wenger RH, Gassmann M, et al. Physiologic responses to hypoxia and implications for hypoxia-inducible factors in the pathogenesis of rheumatoid arthritis. Arthritis Rheum 2004;50:10-23. (Pubitemid 38084283)
8. Radisky DC, Levy DD, Littlepage LE, et al. Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability. Nature 2005;436:123-7. (Pubitemid 40966197)
9. De Bandt M, Grossin M, Driss F, et al. Vitamin E uncouples joint destruction and clinical inflammation in a transgenic mouse model of rheumatoid arthritis. Arthritis Rheum 2002;46:522-32. (Pubitemid 34136591)
10. Cuzzocrea S, McDonald MC, Mota-Filipe H, et al. Beneficial effects of tempol, a membrane-permeable radical scavenger, in a rodent model of collagen-induced arthritis. Arthritis Rheum 2000;43:320-8. (Pubitemid 30395740)
11. Wallace DC. The mitochondrial genome in human adaptive radiation and disease: on the road to therapeutics and performance enhancement. Gene 2005;354:169-80. (Pubitemid 41116698)
12. Taylor RW, Turnbull DM. Mitochondrial DNA mutations in human disease. Nat Rev Genet 2005;6:389-402. (Pubitemid 40577182)
13. Ralph SJ, Rodríguez-Enríquez S, Neuzil J, et al. Bioenergetic pathways in tumor mitochondria as targets for cancer therapy and the importance of the ROS-induced apoptotic trigger. Mol Aspects Med 2010;31:29-59.
14. Choi BO, Hwang JH, Cho EM, et al. Mutational analysis of whole mitochondrial DNA in patients with MELAS and MERRF diseases. Exp Mol Med 2010;42:446-55.
15. Bulua AC, Simon A, Maddipati R, et al. Mitochondrial reactive oxygen species promote production of proinflammatory cytokines and are elevated in TNFR1-associated periodic syndrome (TRAPS). J Exp Med 2011;208:519-33.
16. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24. (Pubitemid 18091653)
17. Taylor W, Gladman D, Helliwell P, et al. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 2006;54:2665-73.
18. van Gestel AM, Haagsma CJ, van Riel PL. Validation of rheumatoid arthritis improvement criteria that include simplified joint counts. Arthritis Rheum 1998;41:1845-50.
19. Fearon U, Veale DJ. Angiogenesis in arthritis: methodological and analytical details. Methods Mol Med 2007;135:343-57.
20. Vermulst M, Bielas JH, Loeb LA. Quantification of random mutations in the mitochondrial genome. Methods 2008;46:263-8.
21. van Kuijk AW, Reinders-Blankert P, Smeets TJ, et al. Detailed analysis of the cell infiltrate and the expression of mediators of synovial inflammation and joint destruction in the synovium of patients with psoriatic arthritis: implications for treatment. Ann Rheum Dis 2006;65:1551-7. (Pubitemid 44799664)
22. Fearon U, Griosios K, Fraser A, et al. Angiopoietins, growth factors, and vascular morphology in early arthritis. J Rheumatol 2003;30:260-8. (Pubitemid 36152587)
23. Bielas JH, Loeb LA. Quantification of random genomic mutations. Nat Methods 2005;2:285-90. (Pubitemid 41131010)
24. Moodley D, Mody G, Patel N, et al. Mitochondrial depolarisation and oxidative stress in rheumatoid arthritis patients. Clin Biochem 2008;41:1396-401.
25. Biniecka M, Fox E, Gao W, et al. Hypoxia induces mitochondrial mutagenesis and dysfunction in inflammatory arthritis. Arthritis Rheum 2011;63:2172-82.
26. Sakon S, Xue X, Takekawa M, et al. NF-kappaB inhibits TNF-induced accumulation of ROS that mediate prolonged MAPK activation and necrotic cell death. EMBO J 2003;22:3898-909. (Pubitemid 36975716)
27. Miesel R, Murphy MP, Kröger H. Enhanced mitochondrial radical production in patients which rheumatoid arthritis correlates with elevated levels of tumor necrosis factor alpha in plasma. Free Radic Res 1996;25:161-9. (Pubitemid 26345346)
28. Ono K, Wang X, Kim SO, et al. Metaxin deficiency alters mitochondrial membrane permeability and leads to resistance to TNF-induced cell killing. Protein Cell 2010;1:161-73.
29. Gurzov EN, Germano CM, Cunha DA, et al. p53 up-regulated modulator of apoptosis (PUMA) activation contributes to pancreatic beta-cell apoptosis induced by proinflammatory cytokines and endoplasmic reticulum stress. J Biol Chem 2010;285:19910-20.
30. Kawai Y, Kubota E, Okabe E. Reactive oxygen species participation in experimentally induced arthritis of the temporomandibular joint in rats. J Dent Res 2000;79:1489-95. (Pubitemid 32489372)
31. Fahmi H, He Y, Zhang M, et al. Nimesulide reduces interleukin-1beta- induced cyclooxygenase-2 gene expression in human synovial fibroblasts. Osteoarthr Cartil 2001;9:332-40. (Pubitemid 32454776)
32. Bresnihan B, Pontifex E, Thurlings RM, et al. Synovial tissue sublining CD68 expression is a biomarker of therapeutic response in rheumatoid arthritis clinical trials: consistency across centers. J Rheumatol 2009;36:1800-2.
33. Pontifex EK, Gerlag DM, Gogarty M, et al. Change in CD3 positive T-cell expression in psoriatic arthritis synovium correlates with change in DAS28 and magnetic resonance imaging synovitis scores following initiation of biologic therapy - a single centre, open-label study. Arthritis Res Ther 2011;13:R7.
34. Kurien BT, Scofield RH. Autoimmunity and oxidatively modified autoantigens. Autoimmun Rev 2008;7:567-73.
35. Poli G, Biasi F, Leonarduzzi G. 4-Hydroxynonenal-protein adducts: A reliable biomarker of lipid oxidation in liver diseases. Mol Aspects Med 2008;29:67-71.
36. Woo CH, Eom YW, Yoo MH, et al. Tumor necrosis factor-alpha generates reactive oxygen species via a cytosolic phospholipase A2-linked cascade. J Biol Chem 2000;275:32357-62.
37. Kageyama Y, Takahashi M, Ichikawa T, et al. Reduction of oxidative stress marker levels by anti-TNF-alpha antibody, infliximab, in patients with rheumatoid arthritis. Clin Exp Rheumatol 2008;26:73-80. (Pubitemid 351385258)
38. Doudican NA, Song B, Shadel GS, et al. Oxidative DNA damage causes mitochondrial genomic instability in Saccharomyces cerevisiae. Mol Cell Biol 2005;25:5196-204. (Pubitemid 40781117)
39. Escames G, López LC, García JA, et al. Mitochondrial DNA and inflammatory diseases. Hum Genet 2011 (In Press).
40. Zhou R, Yazdi AS, Menu P, et al. A role for mitochondria in NLRP3 inflammasome activation. Nature 2011;469:221-5.
41. Nakahira K, Haspel JA, Rathinam VA, et al. Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome. Nat Immunol 2011;12:222-30.
42. Elmali N, Baysal O, Harma A, et al. Effects of resveratrol in inflammatory arthritis. Inflammation 2007;30:1-6. (Pubitemid 46438042)